KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Total Liabilities (2016 - 2025)

Merck (MRK) has disclosed Total Liabilities for 17 consecutive years, with $84.2 billion as the latest value for Q4 2025.

  • On a quarterly basis, Total Liabilities rose 84104.0% to $84.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $84.2 billion, a 84104.0% increase, with the full-year FY2025 number at $84.2 billion, up 84104.0% from a year prior.
  • Total Liabilities was $84.2 billion for Q4 2025 at Merck, up from -$51.8 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $84.2 billion in Q4 2025 to a low of -$51.8 billion in Q3 2025.
  • A 5-year average of $10.4 billion and a median of $325.0 million in 2021 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: crashed 32439.2% in 2024, then soared 84104.0% in 2025.
  • Merck's Total Liabilities stood at $67.4 billion in 2021, then plummeted by 99.11% to $600.0 million in 2022, then crashed by 58.33% to $250.0 million in 2023, then tumbled by 60.0% to $100.0 million in 2024, then skyrocketed by 84104.0% to $84.2 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Total Liabilities are $84.2 billion (Q4 2025), -$51.8 billion (Q3 2025), and $68.5 billion (Q2 2025).